FI944441A0 - Määriteltyjä lipidejä sisältävä farmaseuttinen kantojärjestelmä - Google Patents

Määriteltyjä lipidejä sisältävä farmaseuttinen kantojärjestelmä

Info

Publication number
FI944441A0
FI944441A0 FI944441A FI944441A FI944441A0 FI 944441 A0 FI944441 A0 FI 944441A0 FI 944441 A FI944441 A FI 944441A FI 944441 A FI944441 A FI 944441A FI 944441 A0 FI944441 A0 FI 944441A0
Authority
FI
Finland
Prior art keywords
pct
delivery system
system containing
pharmaceutical delivery
lipid
Prior art date
Application number
FI944441A
Other languages
English (en)
Swedish (sv)
Other versions
FI944441A (fi
FI114140B (fi
Inventor
Haokan Nyqvist
Gert Ragnarsson
Per Tingvall
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of FI944441A0 publication Critical patent/FI944441A0/fi
Publication of FI944441A publication Critical patent/FI944441A/fi
Application granted granted Critical
Publication of FI114140B publication Critical patent/FI114140B/fi

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI944441A 1992-03-27 1994-09-26 Määriteltyjä lipidejä sisältävä kantojärjestelmä FI114140B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9200952 1992-03-27
SE9200952A SE9200952D0 (sv) 1992-03-27 1992-03-27 Pharmaceutical carrier system containing defined lipids
SE9300257 1993-03-26
PCT/SE1993/000257 WO1993019736A1 (en) 1992-03-27 1993-03-26 A pharmaceutical carrier system containing defined lipids

Publications (3)

Publication Number Publication Date
FI944441A0 true FI944441A0 (fi) 1994-09-26
FI944441A FI944441A (fi) 1994-09-26
FI114140B FI114140B (fi) 2004-08-31

Family

ID=20385758

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944441A FI114140B (fi) 1992-03-27 1994-09-26 Määriteltyjä lipidejä sisältävä kantojärjestelmä

Country Status (10)

Country Link
US (1) US5635205A (fi)
EP (1) EP0636020B1 (fi)
JP (1) JPH07508708A (fi)
AT (1) ATE179885T1 (fi)
DE (1) DE69324914T2 (fi)
DK (1) DK0636020T3 (fi)
FI (1) FI114140B (fi)
NO (1) NO308984B1 (fi)
SE (1) SE9200952D0 (fi)
WO (1) WO1993019736A1 (fi)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665379A (en) * 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
SE9402453D0 (sv) * 1994-07-12 1994-07-12 Astra Ab New pharmaceutical preparation
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren
ES2138130T3 (es) * 1995-10-28 2000-01-01 Braun Melsungen Ag Composicion farmaceutica que contiene un anestesico local y/o un analgesico de accion central.
JP2001524958A (ja) * 1997-04-17 2001-12-04 ジーエス ディベロップメント アクティエボラーグ 新規な液晶をベースとする生物接着性薬剤送出系
JP4467789B2 (ja) 1997-09-18 2010-05-26 パシラ ファーマシューティカルズ インコーポレーテッド 持続放出性リポソーム麻酔組成物
IL135989A0 (en) 1997-11-14 2001-05-20 Skyepharma Inc Processes for the production of multivesicular liposomes
AU752225B2 (en) 1998-07-17 2002-09-12 Pacira Pharmaceuticals, Inc. Biodegradable compositions for the controlled release of encapsulated substances
CN1320880C (zh) 1998-12-23 2007-06-13 伊迪亚股份公司 改进的体内局部无创伤用制剂
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
AU2002322024B2 (en) * 2001-05-31 2008-05-08 Pacira Pharmaceuticals, Inc. Encapsulation of nanosuspensions in liposomes and microspheres
EP2209450A4 (en) 2007-11-07 2013-09-25 Svip5 Llc SLOW RELEASE OF LOCAL ANESTHESIC ORGANIC SALTS FOR PAIN RELIEF
WO2011121034A2 (en) 2010-04-01 2011-10-06 Pharmanest Ab Water-free pharmaceutical compositions suitable for local anaesthetics
US9668974B2 (en) 2012-05-10 2017-06-06 Painreform Ltd. Depot formulations of a local anesthetic and methods for preparation thereof
AU2014223993B2 (en) 2013-02-28 2016-09-08 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid formulations and its compostions
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
EP0158441B2 (en) * 1984-03-08 2001-04-04 Phares Pharmaceutical Research N.V. Liposome-forming composition
US5059421A (en) * 1985-07-26 1991-10-22 The Liposome Company, Inc. Preparation of targeted liposome systems of a defined size distribution
SE9003100D0 (sv) * 1990-09-28 1990-09-28 Kabivitrum Ab Lipid formulation system

Also Published As

Publication number Publication date
SE9200952D0 (sv) 1992-03-27
FI944441A (fi) 1994-09-26
DK0636020T3 (da) 1999-11-15
WO1993019736A1 (en) 1993-10-14
FI114140B (fi) 2004-08-31
US5635205A (en) 1997-06-03
NO943543D0 (no) 1994-09-23
EP0636020A1 (en) 1995-02-01
EP0636020B1 (en) 1999-05-12
NO943543L (no) 1994-09-23
ATE179885T1 (de) 1999-05-15
JPH07508708A (ja) 1995-09-28
DE69324914T2 (de) 1999-12-09
NO308984B1 (no) 2000-11-27
DE69324914D1 (de) 1999-06-17

Similar Documents

Publication Publication Date Title
FI944441A0 (fi) Määriteltyjä lipidejä sisältävä farmaseuttinen kantojärjestelmä
ATE333867T1 (de) Emulgierte arzneistoffabgabesysteme
ES2110543T3 (es) Derivados de poli(vinil-aminas) que tienen centros hidrofilos, procedimiento para su preparacion asi como la utilizacion de los compuestos como medicamentos, vehiculos de sustancias activas e ingredientes auxiliares para alimentos.
DE69009185D1 (de) Arzneimittelfreisetzungssystem aus glucan und adjuvant.
ATE171872T1 (de) Arzneimittelzubereitungen zur nasalen verabreichung enthaltend polare stoffwechselprodukte von opiatanalgetika
DK398587D0 (da) Antitumorvirksomt laegemiddel
AU640137B2 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them
ES2165910T3 (es) Administracion nasal y ocular de cetamina para el tratamiento del dolor y para la desintoxicacion.
ATE149828T1 (de) Arzneistofformulierung zur parenteralen anwendung
KR950028767A (ko) 피부통과 투약을 위한 신규의 약제학적 투여 형태
DK0615443T3 (da) Lægemiddel i akut virksom form indeholdende Flurbiprofen og anvendelse deraf
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
CA2129527A1 (fr) Composition pharmaceutique utilisable comme analgesique contenant l'acide (benzoyl-3 phenyl)-2 propionique-(r)
MX9302986A (es) Medicamento que contiene metrifonato y procedimiento para su preparacion
ES2007040A6 (es) Un forma de dosificacion para descargar un agente benificioso a un entorno fluido de uso
DK0483273T3 (da) Ionoforholdig afgivelsesindretning

Legal Events

Date Code Title Description
MA Patent expired